Personalised immunotherapy can keep disease at bay for more than four years
Copy link
Personalised immunotherapy can keep disease at bay for more than four years
Personalised immunotherapy can keep disease at bay for more than four years
Copy link

NHS-backed programme will give men rapid access to new treatments for the best chance of a ‘longer, healthier life’

The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments

Men with high-risk prostate cancer that has not yet spread now qualify for the treatment

Study finds targeted treatment method has less than half the risk of dysfunction compared with standard techniques

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the disease…

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank…